01826nam 2200505zu 450 991037572100332120210807005133.0(CKB)3780000000084560(SSID)ssj0001254559(PQKBManifestationID)11819396(PQKBTitleCode)TC0001254559(PQKBWorkID)11223821(PQKB)11283078(WaSeSS)IndRDA00021723(Association for Computing Machinery)10.1145/2530544(EXLCZ)99378000000008456020160829d2013 uy engur|||||||||||txtccrProceedings of the 2012 Workshop on Embedded and Cyber-Physical Systems Education (WESE) : October 12, 2012, Tampere, Finland[Place of publication not identified]ACM20131 online resource (71 pages)ACM ConferencesBibliographic Level Mode of Issuance: Monograph1-4503-1765-0 ACM ConferencesWESE 2012Proceedings of the Workshop on Embedded and Cyber-Physical Systems EducationElectrical & Computer EngineeringHILCCEngineering & Applied SciencesHILCCElectrical EngineeringHILCCElectrical & Computer EngineeringEngineering & Applied SciencesElectrical EngineeringMarwedel Peter748846Marwedel PeterAssociation for Computing Machinery-Digital Library.PQKBBOOK9910375721003321Proceedings of the 2012 Workshop on Embedded and Cyber-Physical Systems Education (WESE) : October 12, 2012, Tampere, Finland1961183UNINA04951nam 22016093a 450 991034684330332120250203235431.09783038970668303897066210.3390/books978-3-03897-066-8(CKB)4920000000095207(oapen)https://directory.doabooks.org/handle/20.500.12854/58295(ScCtBLL)7724aed1-8acc-447b-a70d-a7226fbf8ce8(OCoLC)1117885981(EXLCZ)99492000000009520720250203i20192019 uu engurmn|---annantxtrdacontentcrdamediacrrdacarrierResearch of Pathogenesis and Novel Therapeutics in ArthritisChih-Hsin TangBasel, Switzerland :MDPI,2019.1 electronic resource (366 p.)9783038970651 3038970654 Arthritis has a high prevalence globally and includes over 100 different types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for arthritis patients. This book summarizes and discusses the global picture of the current understanding of arthritis.receptor activator of nuclear factor ?Binfliximabtripterinetriptolideosteoblasttumor necrosis factor-alphasynovial cellanti-arthritisbiosimilarsEpstein-Barr viruscytokinesSOX9parathyroid hormonenitric oxideratetanerceptangiogenesisglycosylationmitogen activated protein kinaseTh9 lymphocytesrheumatoid arthritisIL-6clodronatebone erosionmesenchymal stem cellscollagen-induced arthritisbiologicalgene expressioninflammatory arthritisosteoarthritisfraxinellonenuclear factor kappa Bmessenger RNAinflammationmiRNAdisease-modifyingadipokinesWNTglycoprotein 42miR-199a-5pproliferationnext-generation sequencingcollagenosteoarthritis (OA)experimental arthritisbone morphogenetic proteinTNF-?computational modelingbasic researchosteoclasttherapeuticscertolizumab pegolchondrocytesprogenitor cellsadjuvant arthritisadalimumabtriterpenoidsclareolTNF?fibroblast growth factor 2antibodiesosteoblastsmolecular pathologyTh17immunologyobesityvisfatinarticular cartilageautoimmunebiomarkerscelastrolMAPKdisease pathwaysIL1?arthritisbioinformaticsanticitrullinated peptide antibodiesdrug delivery systemantagonistsshared epitopepathologySMA- and MAD-related proteinsmall-molecule inhibitortransforming growth factor ?micegolimumabspinal fusionantirheumatic drugearly osteoarthritisstem cellrheumatoid factortherapeutic antibodybisphosphonateosteoclastogenesisinterleukinspondyloarthropathiesclinical translationtherapyTraditional Chinese medicinechemokinesstructurecell signalingmicroRNATang Chih-Hsin1305960ScCtBLLScCtBLLBOOK9910346843303321Research of Pathogenesis and Novel Therapeutics in Arthritis3028066UNINA